Welcome to our dedicated page for Bed Bath & Beyond SEC filings (Ticker: BBBY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bed Bath & Beyond, Inc. (NYSE: BBBY) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8-K and related exhibits. These filings offer detailed insight into Bed Bath & Beyond’s strategy as an ecommerce-focused "Everything Home" company with home retail brands and a blockchain asset portfolio.
In its Form 8-K filings, Bed Bath & Beyond reports on a range of material events. These include merger and acquisition agreements, such as the Agreement and Plan of Merger under which a wholly owned subsidiary of Bed Bath & Beyond will merge with The Brand House Collective, Inc., subject to customary closing conditions. The filing describes the exchange ratio, treatment of equity awards, conditions to closing, termination rights, and potential termination fees, giving investors a structured view of the proposed transaction.
Other 8-Ks detail credit and financing arrangements, including an Amended and Restated Term Loan Credit Agreement and subsequent amendments with The Brand House Collective, delayed-draw term loan commitments that are convertible into equity, and additional commitments disclosed in later amendments. Filings also describe Bed Bath & Beyond’s participation in loans issued by The Container Store, Inc. via participation agreements, outlining aggregate purchase prices and the rights to interest and repayment associated with these positions.
Capital markets actions are another key focus of the company’s SEC disclosures. Bed Bath & Beyond has filed materials related to a warrant dividend distribution to shareholders, including a Warrant Agreement, registration statements for shares issuable upon exercise of the warrants, and detailed terms covering exercise price, expiration, early expiration conditions, and listing applications for the warrants under the ticker BBBY WS.
Filings further cover corporate governance and compensation matters, such as the adoption of the 2025 Employment Inducement Equity Incentive Plan under NYSE Rule 303A.08, and the appointment of Marcus Lemonis as Chief Executive Officer in addition to his role as Executive Chairman and principal executive officer. Results of operations and financial condition are furnished through earnings-related 8-Ks, which reference press releases and presentations with quarterly financial data and key operating metrics.
On Stock Titan, these filings are updated as they are released on EDGAR. AI-powered summaries help explain the significance of each document, from merger agreements and credit amendments to warrant distributions and executive appointments, so users can more quickly understand how each filing relates to Bed Bath & Beyond’s home-focused retail, services, and blockchain strategy.
Lee Adrianne reported acquisition or exercise transactions in this Form 4 filing.
Bed Bath & Beyond, Inc. President & CFO Adrianne Lee received a grant of 100,000 restricted stock units (RSUs), each representing a contingent right to one share of common stock. This is a compensation-related award, not an open-market stock purchase or sale.
The RSUs vest in three equal installments at the close of business on February 17, 2027, February 17, 2028 and February 17, 2029. Vested shares will be delivered to Lee promptly after each vesting date, and the 100,000 RSUs shown reflect the amount from this grant beneficially owned following the reported transaction.
Putnam Leah R reported acquisition or exercise transactions in this Form 4 filing.
BED BATH & BEYOND, INC. Chief Accounting Officer Leah R. Putnam reported receiving a grant of 40,000 restricted stock units (RSUs), each representing a right to one share of common stock. These RSUs vest in three equal installments on February 17, 2027, February 17, 2028, and February 17, 2029, with shares delivered promptly after each vesting date. Following this grant, she beneficially owns 40,000 RSUs from this award.
Bed Bath & Beyond executive chairman and CEO Marcus Lemonis reported a series of equity compensation transactions on March 10, 2026. He exercised 166,666 restricted stock units and 141,432 performance shares into an equal number of common shares at a conversion price of $0.00 per share.
He also received common stock awards of 166,666 and 141,432 shares, while 59,813 and 34,680 shares were withheld at $4.91 per share to cover tax obligations. After these vesting and tax-withholding transactions, Lemonis directly holds 669,756 shares of Bed Bath & Beyond common stock.
Bed Bath & Beyond Chief Accounting Officer Leah R. Putnam reported routine equity compensation activity. On March 2, 2026, 1,000 restricted stock units were exercised into 1,000 shares of common stock at a price of $0.00 per share. As part of the same event, 244 shares of common stock at $5.18 per share were withheld to cover tax obligations. Each restricted stock unit represents one share of common stock and vested in three equal installments on March 2, 2024, March 2, 2025 and March 2, 2026. Following these transactions, Putnam directly owned 16,554 shares of Bed Bath & Beyond common stock.
Bed Bath & Beyond, Inc. files its annual report outlining its evolution into an e‑commerce‑focused home retailer built around the Bed Bath & Beyond, Overstock, buybuy BABY and Kirkland’s brands. The company operates an asset‑light marketplace model, with most orders fulfilled by third‑party partners.
The report highlights an omni‑channel relaunch via a pending merger with The Brand House Collective (owner of converted Bed Bath & Beyond neighborhood stores), significant competition from large online and brick‑and‑mortar rivals, and reliance on digital marketing and search. It also notes an accumulated deficit of $842.7 million, equity method investments of $66.6 million, and a workforce of 389 employees as of December 31, 2025, supported by extensive human‑capital and culture initiatives.
Bed Bath & Beyond Executive Chairman Marcus Lemonis lays out a plan to stabilize and grow the company following 2025. Management prioritized margin integrity over top-line revenue, narrowing the year‑over‑year revenue gap in Q4 and improving adjusted EBITDA loss by 84% (approximately $23 million).
The company is targeting full‑year 2026 revenue growth of low‑ to mid‑single digits, expects gross margin in the 24%–26% range, and says it has lowered its breakeven point through SKU/vendor rationalization. Pending transactions include the anticipated closing of Kirkland’s, which the company says would bring combined annualized revenue to approximately $1.5 billion, plus an additional in‑principle omni‑channel transaction expected to add about $500 million of annualized revenue. A Form S‑4/proxy has been filed in connection with the TBHC merger.
Bed Bath & Beyond, Inc. reported fourth-quarter 2025 net revenue of $273 million, down 9.8% year-over-year, but continued its eighth straight quarter of measurable progress toward profitability. Gross margin improved to 24.6% and the quarterly net loss narrowed to $21 million, a $60 million improvement.
For full-year 2025, net revenue was $1.0 billion, down 25.1% year-over-year, while net loss narrowed to $85 million from $259 million and adjusted EBITDA loss improved to $31 million from $144 million. Operating cash flow use improved by $118 million and free cash flow improved to negative $64 million. The company expects low- to mid-single digit revenue growth in 2026 while maintaining disciplined margin and cost management.
Amplify Blockchain Technology ETF, a series of Amplify ETF Trust, reported a significant ownership stake in Bed Bath & Beyond, Inc. common stock. As of 12/31/2025, the fund beneficially owned 5,693,135 shares, representing about 8.3% of the outstanding common stock.
The ETF has sole power to vote and dispose of all these shares, with no shared voting or dispositive power. It states that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Bed Bath & Beyond.
Amplify Blockchain Technology ETF, a Massachusetts-based series of Amplify ETF Trust, filed an amended Schedule 13G reporting its ownership in Bed Bath & Beyond Inc. common stock. The filing states the fund now holds 5 percent or less of the company’s outstanding shares.
The ETF certifies that the Bed Bath & Beyond shares were acquired and are held in the ordinary course of business, not to change or influence control of the company, and not in connection with any control-related transaction. The ETF is a registered investment company, confirming a passive, institutional holder status.
Bed Bath & Beyond Executive Chairman and CEO Marcus Lemonis reported new equity awards. On February 4, 2026, he acquired 424,300 performance shares, each representing the right to receive one share of common stock, at a stated value of $0.001 per performance share.
These performance shares were originally granted on March 10, 2025 and are scheduled to vest in three equal installments on March 10, 2026, March 10, 2027, and March 10, 2028, based on continued service and previously determined performance results for fiscal 2025. The filing also reports 45,615 common stock warrants that were issued on October 7, 2025 as a pro‑rata distribution to all common shareholders, each with an exercise price of $15.50 per warrant.